Mwandishi:
Dkt. Mercy M, CO
Mhariri:
Dkt. Benjamina L, MD
Isosorbide mononitrate ni moja kati ya dawa inayotumika kutibu na kuzuia maumivu ya kifua (Angina) kwa wagonjwa wenye matatizo ya mishipa ya damu ya koronari.
Majina ya kibiashara
Majina kibiashara ya Isosorbide mononitrate ni pamoja na;
Imolur
Monoket
ISMO
Isosorbide mononitrate ipo kundi gani la dawa?
Isosorbide mononitrate ni dawa iliyo katika kundi la Nitrates, Angina.
Dawa zilizo kundi moja na Isosorbide mononitrate
Dawa zilizo kundi moja na Isosorbide mononitrate ni ;
Nitrogycerin
Hydralazine
Isosorbide dinitrate
Minoxidil
Fenoldopam
Nitroprusside
Fomu ya dawa ya Isosorbide mononitrate
Dawa hii ipo katika fomu ya kidonge
Uzito wa dawa ya Isosorbide mononitrate
Isosorbide mononitrate ina uzito ufuatao;
Vidonge
10mg
20mg
Vidonge ( vinavyofanya kazi muda mrefu)
30mg
60mg
120mg
Isosorbide mononitrate hutibu nini?
Hutumika kutibu Angina pectoris.
Namna Isosorbide mononitrate inavyoweza kufanya kazi
Isosorbide mononitrate inapoingia kwenye damu hufanya kazi ya kupanua mishipa ya damu moja kwa moja hasa kwenye ateri na veini kidogo hivyo kupunguza shinikizo la damu na kufanya damu izunguke vizuri mwilini.
Ufyozwaji wa dawa
Ufyozwaji wa dawa hii hufanyika vizuri kwenye mfumo wa chakula itumike nusu saa kabla mtu hajapata chakula au saa moja baada ya kula.
Mwingiliano wa Isosorbide mononitrate na chakula
Dawa hii ni nzuri ikutumika nusu saa kabla ya kula au saa moja baada ya kula chakula.
Wagonjwa wasiopaswa kutumia Isosorbide mononitrate
Wagonjwa wenye mzio wa Isosorbide mononitrate.
Wagonjwa wenye mzio wa dawa jamii ya Nitrates.
Utoaji taka wa Isosorbide mononitrate mwilini
Asilimia mbili (2%) ya dawa hii hutolewa kwa njia ya mkojo na asilimia moja (1%) ya dawa hutolewa kwa njia ya haja kubwa.
Matumizi ya Isosorbide mononitrate kwa mama mjamzito
Tafiti zinaonesha kuwa tahadhari inatakiwa wakati mama mjamzito anatumia dawa hii inaweza kuleta madhara kwa mtoto aliye tumboni kwa mama.
Matumizi ya Isosorbide mononitrate mama anayenyonyesha
Hakuna tafiti zinazoonesha kama dawa hii inaingia kwenye maziwa ya mama, ina madhara ya mtoto na katika uzalishwaji wa maziwa hivyo tahadhari inatakiwa wakati mama anatumia dawa hii.
Dawa zenye muingiliano na Isosorbide mononitrate
Dawa zenye mwingiliano mkali na hivyo kutofaa kutumika pamoja na Isosorbide mononitrate;
Abametapir
Apalutamide
Cabergoline
Carbamazepine
Ergoloid mesylates
Ergotamine
Fexinidazole
Fosphenytoin
Idelalisib
Ivosidenib
Lofexidine
Methylergonovine
Phenobarbital
Phenytoin
Tucatinib
Voxelotor
Dawa zinazoweza kutumika na Isosorbide mononitrate chini ya uangalizi;
Arginine
Belzutifan
Bosentan
Bretylium
Bupivacaine implant
Captopril
Cenobamate
Conivaptan
Crofelemer
Dabrafenib
Dapsone topical
Dichlorphenamide
Duvelisib
Efavirenz
Elagolix
Elvitegravir/cobicistat/emtricitabine/tenofovir df
Encorafenib
Etravirine
Fedratinib
Iloperidone
Istradefylline
Lorlatinib
Maraviroc
Mitotane
Nafcillin
Nitroglycerin rectal
Primidone
Ribociclib
Rifabutin
Rucaparib
Stiripentol
Tazemetostat
Tecovirimat
Tetracaine
Dawa zenye mwingiliano mdogo na Isosorbide mononitrate;
Acetyl cysteine (Antidote)
Rifampin
Rifapentine
Maudhi madogo ya Isosorbide mononitrate;
Shinikizo la damu kuwa chini
Kichefuchefu
Maumivu ya kichwa
Palpitation
Macho kutoa uchafu na kuwa mekundu
Kichefuchefu
Mapigo ya moyo kuwa juu
Mwili kuvimba
Vascular collapse
Peripheral neuropathy
Kukosa hamu ya kula
Kuharisha
Kutapika
Kizunguzungu
Maumivu ya kifua
Kushindwa kupumua
Mwili kuchoka
Ufanye nini endapo utasahau kutumia dozi yako?
Kama umesahau kutumia dozi yako tumia mara pale utakapokumbuka kama muda wa dozi uliyosahau ni ndani ya masaa sita, ila kama umesahau zaidi ya masaa sita usimeze dozi uliyosahau endelea na dozi inayofuata kwa muda uliopangiwa na daktari. Usimeze dozi mbili kufidia uliyosahau.
13 Juni 2023 19:18:46
Dawa Isosorbide mononitrate
Imeboreshwa,
29 Oktoba 2021 13:56:15
Dawa yoyote ni sumu, usitumie dawa pasipo ushauri wa daktari kuepuka madhara kwenye ogani mbalimbali kama figo na ini. Matumizi ya dawa pasipo ushauri wa daktari unaweza kusababisha madhara na usugu wa vimelea vya maradhi kwenye dawa.
ULY CLINIC inakushauri siku zote uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baad aya kusoma makala hii.
Kupata ushauri zaidi na tiba kutoka kwa daktari wa ULY CLINIC bofya Mawasiliano yetu au Pata tiba.
Rejea za mada hii:
Bäck SE, et al. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest. 1989 Nov;49(7):641–646.
Bax RP, et al. The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):311–320.
Burman LA, et al. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. J Antimicrob Chemother. 1991 Feb;27(2):219–224.
Christensson BA, et al. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrob Agents Chemother. 1992 Jul;36(7):1532–1537.
DAVIES DF, SHOCK NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507.
Douglas JG, et al. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother. 1980 Jul;6(4):543–549.
Granerus G, et al. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest. 1981 Oct;41(6):611–616.
Harrison MP, et al. The disposition and metabolism of meropenem in laboratory animals and man. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):265–277.
Jones RN, et al. In-vitro studies of meropenem. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):9–29.
Krutzén E, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med. 1984 Dec;104(6):955–961.
Ljungberg B, et al. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis. 1987 Mar-Apr;9(2):250–264.